X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-12-21 | SYRS | Akkaraju Srinivas | Dir | P - Purchase | $4.42 | +904,977 | 1,789,093 | +102% | +$3,999,998 | ||||||
2023-12-12 | SYRS | Roth David | Chief Medical Officer | S - Sale | $4.95 | -6,287 | 0 | -100% | -$31,121 | ||||||
2023-12-06 | SYRS | Roth David | Chief Medical Officer | S - Sale | $3.95 | -6,287 | 6,287 | -50% | -$24,834 | ||||||
2023-07-31 | SYRS | Roth David | Chief Medical Officer | S - Sale | $3.95 | -7,348 | 0 | -100% | -$29,025 | ||||||
2023-07-17 | SYRS | Olson Eric R | Chief Scientific Officer | S - Sale | $3.50 | -689 | 6,661 | -9% | -$2,412 | ||||||
M | 2022-09-29 | SYRS | Tyson Timothy | Dir | P - Purchase | $6.26 | +16,932 | 24,932 | +212% | +$105,955 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |